These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16403816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
    Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, Salmi J, Välimäki M, Någren K, Nuutila P.
    J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
    Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, Azizan EA, Aigbirhio F, Gurnell M, Brown MJ.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
    [Abstract] [Full Text] [Related]

  • 6. 11C-metomidate PET imaging of adrenocortical cancer.
    Khan TS, Sundin A, Juhlin C, Långström B, Bergström M, Eriksson B.
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
    Bergström M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerström G, Långström B.
    J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
    Kreissl MC, Schirbel A, Fassnacht M, Haenscheid H, Verburg FA, Bock S, Saeger W, Knoedler P, Reiners C, Buck AK, Allolio B, Hahner S.
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
    Lu CC, Chen CJ, Peng KY, Chueh JS, Chang CC, Yen RF, Wu VC, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group.
    Clin Nucl Med; 2022 Nov 01; 47(11):936-942. PubMed ID: 36215396
    [Abstract] [Full Text] [Related]

  • 18. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
    Watanabe H, Kanematsu M, Goshima S, Kondo H, Kawada H, Noda Y, Moriyama N.
    Ann Nucl Med; 2013 Aug 01; 27(7):648-53. PubMed ID: 23625579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
    Bergström M, Bonasera TA, Lu L, Bergström E, Backlin C, Juhlin C, Långström B.
    J Nucl Med; 1998 Jun 01; 39(6):982-9. PubMed ID: 9627330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.